You have 9 free searches left this month | for more free features.

Pevonedistat

Showing 1 - 25 of 32

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Terminated
  • Locally Advanced Malignant Solid Neoplasm
  • +2 more
  • Pembrolizumab
  • Pevonedistat
  • Houston, Texas
    M D Anderson Cancer Center
Dec 22, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Leukemia, Myeloid, Acute, MDS Trial in Japan, Korea, Republic of, Taiwan (Pevonedistat 25 mg/m^2, Pevonedistat 44 mg/m^2,

Completed
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • Pevonedistat 25 mg/m^2
  • +4 more
  • Maebashi City, Japan
  • +8 more
Jun 23, 2022

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Miami (Pevonedistat, Vincristine,

Completed
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Pevonedistat
  • +7 more
  • Miami, Florida
    University of Miami
Oct 19, 2022

Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Acute Myeloid Leukemia Trial in United States

Active, not recruiting
  • Recurrent Acute Myeloid Leukemia
  • +3 more
  • Tampa, Florida
  • +5 more
Nov 18, 2022

Mesothelioma Trial in United States (pevonedistat, Pemetrexed and cisplatin)

Active, not recruiting
  • Mesothelioma
  • pevonedistat
  • Pemetrexed and cisplatin
  • Basking Ridge, New Jersey
  • +7 more
Sep 12, 2022

MDS, Myeloproliferative Tumor Trial in United States (Azacitidine Subcutaneous Injection or Intravenous Infusion, Pevonedistat

Active, not recruiting
  • Myelodysplastic Syndromes
  • Myeloproliferative Neoplasm
  • Azacitidine Subcutaneous Injection or Intravenous Infusion
  • +2 more
  • Miami, Florida
  • +4 more
Jun 20, 2022

Myelofibroses Trial in Saint Louis (Pevonedistat, Ruxolitinib, Peripheral blood draw)

Terminated
  • Myelofibroses
  • Pevonedistat
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 16, 2021

NSCLC Trial in Ann Arbor (Pevonedistat, Docetaxel)

Terminated
  • Non-small Cell Lung Cancer
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Dec 16, 2021

Acute Myelogenous Leukemia, AML, Advanced MDS Trial in Miami (Pevonedistat, Cytarabine)

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • Miami, Florida
    University of Miami
Dec 7, 2021

MDS (MDS) Trial (Pevonedistat, Decitabine, Cedazuridine)

Withdrawn
  • Myelodysplastic Syndromes (MDS)
  • Pevonedistat
  • +2 more
  • (no location specified)
Sep 23, 2021

MDS Trial (Pevonedistat, Azacitidine)

No longer available
  • Myelodysplastic Syndromes
  • (no location specified)
Sep 8, 2021

Metastatic Lung Non-Small Cell Squamous Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer

Active, not recruiting
  • Metastatic Lung Non-Small Cell Squamous Carcinoma
  • +7 more
  • Los Angeles, California
  • +9 more
Dec 17, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Myelodysplasia-Related

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Tucson, Arizona
  • +2 more
Aug 5, 2022

Recurrent Lymphoma, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan,

Active, not recruiting
  • Recurrent Lymphoma
  • +5 more
  • Birmingham, Alabama
  • +19 more
Oct 20, 2022

Acute Myeloid Leukemia in Remission, MDS, Minimal Residual Disease Trial in Germany (Pevonedistat, Azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia in Remission
  • +2 more
  • Aachen, Germany
  • +13 more
Jul 11, 2022

Acute Myelogenous Leukemia Trial in Rochester, Milwaukee (Azacitidine, Venetoclax, Pevonedistat)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Rochester, Minnesota
  • +1 more
Sep 21, 2021

Advanced Solid Tumor Trial in United States (Pevonedistat, Docetaxel, Carboplatin)

Completed
  • Advanced Solid Neoplasm
  • Pevonedistat
  • +3 more
  • Santa Monica, California
  • +7 more
Jun 22, 2021

Leukemia, Myeloid, Acute Trial in Portugal, Spain (Pevonedistat, Azacitidine)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Coimbra, Portugal
  • +63 more
Sep 9, 2022

Acute Myeloid Leukemia (AML) Trial in Hershey (Pevonedistat, transplant, Azacitidine)

Terminated
  • Acute Myeloid Leukemia (AML)
  • Pevonedistat
  • +2 more
  • Hershey, Pennsylvania
    Penn State Hershey Medical Center: Penn State Cancer Institute
Nov 22, 2020

MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Pevonedistat)

Completed
  • Myelodysplastic Syndromes
  • +2 more
  • Birmingham, Alabama
  • +58 more
Aug 24, 2022

Advanced Solid Tumors, Tumors, Advanced Solid Trial in Budapest (Pevonedistat, [14C]-Pevonedistat, Docetaxel)

Completed
  • Advanced Solid Tumors, Neoplasms, Advanced Solid
  • Pevonedistat
  • +4 more
  • Budapest, Hungary
  • +1 more
Nov 4, 2019

Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine,

Active, not recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • Daphne, Alabama
  • +241 more
Dec 23, 2022

Solid Tumors Trial in United States (MLN4924, Paclitaxel, Gemcitabine)

Completed
  • Solid Tumors
  • Atlanta, Georgia
  • +5 more
Jun 5, 2020

Previously Untreated Acute Myeloid Leukemia Trial in United States (biological, other, drug)

Recruiting
  • Previously Untreated Acute Myeloid Leukemia
  • Samalizumab (BAML-16-001-S1)
  • +32 more
  • Phoenix, Arizona
  • +18 more
Oct 17, 2022